Faculty profile

Nathan Perlis

ResearcherUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses may be missing. Find their university profile.

Nathan Perlis

Researcher

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
48 publications in the last five years, latest in 2026.
Senior (last) author on 6 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2019.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

279

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Prostate Cancer

Latest papers

Irreversible electroporation in focal therapy for prostate cancer: current status and future directions.
Prostate international · 2026
A survey of Canadian urologists' and radiologists' perspectives regarding the use of prostate MRI in biopsy-naive patients.
Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2026
PA- versus urologist-performed flexible cystoscopy: A comparative study.
JAAPA : official journal of the American Academy of Physician Assistants · 2026

All 99 publications

Latest funding

Development, multi-ancestry international validation, algorithmic audit, and prospective silent trial evaluation of PRISM - A globally accessible, patient-oriented artificial intelligence-based model to predict the presence of clinically significant prostate cancer
CIHR · 2023 · Co-investigator
$462,824
Comprehensive Health Assessment for My Plan: initial implementation study (CHAMP implementation study)
CIHR · 2022 · Co-investigator
$229,500
A Web-Based Peer Navigation Program for Men with Prostate Cancer: A Hybrid Effectiveness-Implementation Trial
CIHR · 2020 · Co-investigator
$569,926

All 9 grants and awards

99 publications.

Irreversible electroporation in focal therapy for prostate cancer: current status and future directions.

Durazo-Ruiz FO, Roldán-Testillano R, Rodriguez-Sanchez L, Laguna MP, Mendez-Bisgaard LN, Arezki A, Elkhatib H, Hevia-Feliu A, Zhang K, Fainberg J, Perlis N, Rosette J, Miñana-López B, de Reijke TM, Anidjar M, Emberton M, Stricker PD, Sanchez-Salas R

Prostate international2026

DOI: 10.1016/j.prnil.2025.11.001 PMID: 42382550

A survey of Canadian urologists' and radiologists' perspectives regarding the use of prostate MRI in biopsy-naive patients.

Cheung DC, Kaushal S, Lund A, Martin LJ, Komisarenko M, Perlis N, Ghai S, Alibhai SMH, Kulkarni GS, Haider MA, Finelli A

Canadian Urological Association journal = Journal de l'Association des urologues du Canada2026

DOI: 10.5489/cuaj.9634 PMID: 42678684

PA- versus urologist-performed flexible cystoscopy: A comparative study.

Misurka J, Berjaoui MB, Lajkosz K, Cockburn J, Kot D, Hamilton RJ, Kulkarni GS, Zlotta AR, Lee JY, Perlis N, Finelli A, Fleshner NE

JAAPA : official journal of the American Academy of Physician Assistants2026

DOI: 10.1097/01.jaa.0000000000000323 PMID: 41723868

Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancer.

Pace KJC, Kwong JCC, Randhawa H, Ringa M, Al-Daqqaq Z, Chelliahpillai Y, Lee S, Kim K, Haile S, Ali A, Wettstein M, Chan A, Perlis N, Lee J, Hamilton R, Fleshner N, Finelli A, Jamal M, Papanikolaou F, Short T, Feifer A, Kulkarni G, Zlotta AR

BJU international2026

DOI: 10.1111/bju.70085 PMID: 41260885

Membranous urethral length as a predictor for urinary incontinence after holmium enucleation of the prostate for benign prostatic hyperplasia.

Lee N, Benzouak T, Nguyen DD, Belliveau S, Murad L, Kadi L, Perlis N, Breau RH, Elterman D, Chughtai B, Gralnek DR, Olivié D, Meskawi M, Negrean C, Bhojani N

World journal of urology2026

DOI: 10.1007/s00345-026-06232-4 PMID: 41615485

External Validation and Comparison of Magnetic Resonance Imaging-based Risk Calculators for Detection of Clinically Significant Prostate Cancer: A Multi-institutional Study Incorporating Transrectal and Transperineal Biopsy Approaches.

Zlotta AR, Taborek A, Kwong JCC, Wang A, Boulakia N, Yin LB, Zhang KK, Nguyen DD, Srigley JR, der Kwast TV, Prendeville S, Booth R, Shahid A, Ringa M, Ali A, Diamond I, Bruni S, Klotz LH, Perlis N, Fleshner N, Finelli A, Diamand R, Ghai S, Haider M, Buckley R, Feifer A, Mian BM, Kulkarni GS

European urology focus2026

DOI: 10.1016/j.euf.2026.06.027 PMID: 42763233

Prostate MRI learning curves: establishing training benchmarks for radiology and urology trainees.

Stegarescu P, Burian E, Lutz A, Perlis N, Grosse U, Avramovic N, Benev S, Bolz C, Götz P, Koschler M, Kostova J, Macek A, Martin Mens A, Namdar K, Popa I, Satari A, Schmidt S, Töckelt F, Wiegele R, Klein J, Herrmann T, Andreisek G, Deniffel D

European radiology2026

DOI: 10.1007/s00330-025-12177-w PMID: 41402568

[18F]F-DCFPyL PET/MRI radiomics for intraprostatic prostate cancer detection and metastases prediction using whole-gland segmentation.

Mirshahvalad SA, Basso Dias A, Ortega C, Abreu Gomez JA, Krishna S, Perlis N, Berlin A, van der Kwast T, Jhaveri K, Ghai S, Metser U, Santiago AT, Veit-Haibach P

The British journal of radiology2025

DOI: 10.1093/bjr/tqaf014 PMID: 39847533

Prostate-specific antigen density does not predict metastatic disease on PSMA-PET in high-risk prostate cancer patients with negative conventional imaging.

Kumar R, Lajkosz K, Metser U, Misurka J, Hiemstra J, Kreidstein J, Calicchia L, Silberman A, Finelli A, Fleshner NE, Hamilton RJ, Kulkarni GS, Zlotta A, Berlin A, Perlis N

Canadian Urological Association journal = Journal de l'Association des urologues du Canada2025Senior author

DOI: 10.5489/cuaj.9113 PMID: 40392159

Impact of concomitant carcinoma in situ distribution on non-muscle-invasive bladder cancer progression risk.

Kwong JCC, Pace K, Al-Daqqaq Z, Chelliahpillai Y, Lee S, Kim K, Ringa M, Ali A, Wettstein M, Chan A, Lajkosz K, van der Kwast T, Perlis N, Lee JY, Hamilton RJ, Fleshner NE, Finelli A, Jamal M, Papanikolaou F, Short T, Feifer A, Kulkarni GS, Zlotta AR

BJU international2025

DOI: 10.1111/bju.16793 PMID: 40415640

Something wrong or missing on this profile? Suggest a correction

Nathan Perlis

Research

Latest papers

Latest funding

Irreversible electroporation in focal therapy for prostate cancer: current status and future directions.

A survey of Canadian urologists' and radiologists' perspectives regarding the use of prostate MRI in biopsy-naive patients.

PA- versus urologist-performed flexible cystoscopy: A comparative study.

Risk of metachronous upper tract urothelial carcinoma following non-muscle-invasive bladder cancer.

Membranous urethral length as a predictor for urinary incontinence after holmium enucleation of the prostate for benign prostatic hyperplasia.

External Validation and Comparison of Magnetic Resonance Imaging-based Risk Calculators for Detection of Clinically Significant Prostate Cancer: A Multi-institutional Study Incorporating Transrectal and Transperineal Biopsy Approaches.

Prostate MRI learning curves: establishing training benchmarks for radiology and urology trainees.

[18F]F-DCFPyL PET/MRI radiomics for intraprostatic prostate cancer detection and metastases prediction using whole-gland segmentation.

Prostate-specific antigen density does not predict metastatic disease on PSMA-PET in high-risk prostate cancer patients with negative conventional imaging.

Impact of concomitant carcinoma in situ distribution on non-muscle-invasive bladder cancer progression risk.

Frequent collaborators

Antonio Finelli

Neil Fleshner

Alejandro Berlin

Girish Kulkarni

Alexandre Zlotta

Robert Hamilton

Patrick Veit-Haibach

Shabbir Alibhai

Carol Mulder

Stuart Peacock

Janet Papadakos

Lauren Lapointe-Shaw

David Wiljer

Joseph Cafazzo

Stuart Peacock

George Tomlinson

Beate Sander

Andrew Mendlowitz

ANDREW FEIFER

Miles Mannas

Mary Gospodarowicz

Paul Grootendorst

Lisa Avery

Keith Jarvi

Tony Lam

Jennifer Walker

Beate Sander

Andrew Mendlowitz

Emery Potter

Dean Elterman

Xuan Li

Amy Liu

Andrew Loblaw

Wassim Kassouf

Paul Ritvo

John F Valliant

Paul Grootendorst

Murray Krahn

Andreas Laupacis

David Cherney